Welcome to the 6th DDR Inhibitors Summit! DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-treat CNS tumors.
                                    
                                        
                                             
                                            24-26 January 2023